Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02SNY
|
|||
Former ID |
DIB013726
|
|||
Drug Name |
WF-10
|
|||
Synonyms |
Macrokine; TCDO; Tetrachlorodecaoxide; OXO-K993
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Acquired immune deficiency syndrome [ICD-11: 1C62.3; ICD-9: 42] | Phase 2 | [1] | |
Company |
Dimethaid AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
Cl4H2O11-4
|
|||
Canonical SMILES |
O.[O-]Cl=O.[O-]Cl=O.[O-]Cl=O.[O-]Cl=O.O=O
|
|||
InChI |
1S/4ClHO2.O2.H2O/c4*2-1-3;1-2;/h4*(H,2,3);;1H2/p-4
|
|||
InChIKey |
VOWOEBADKMXUBU-UHFFFAOYSA-J
|
|||
CAS Number |
CAS 92047-76-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00002244) A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.